We selected the ratio for functional tests based on data in our possession concerning the number of CD41+ EVs present in platelet concentrates and the number of transfusion units administered to polytransfused patients with hematological malignancies (12, 29). The gene discussed is ITGA2B; the disease is hematologic disorder.